Compound Detail
CHEMBL5396996
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5396996 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | NLSDSLMVLQCDGX-UHFFFAOYSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
427.5
MW (Da)
4.45
ALogP
5
HBA
1
HBD
85.3
PSA (Ų)
0.70
QED
0
Ro5 Violations
7
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 5.28
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| beta-catenin-B-cell lymphoma 9 protein complex CHEMBL3885525 | IC50 | 5.28 | 5.28 | 5270.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| beta-catenin-B-cell lymphoma 9 protein complex | IC50 | = | 5270.0 | nM | 5.28 | Inhibition of N-terminal His6-tagged full-length recombinant beta-catenin (1 to ... | 36630177 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 36630177 | 10.1021/acs.jmedchem.2c01568 | beta-catenin-B-cell lymphoma 9 protein complex | 2 |
Data from ChEMBL 36 via Core Engine